| 000 | 01629 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514170035.0 | ||
| 264 | 0 | _c20040511 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1060-0280 | ||
| 024 | 7 |
_a10.1345/aph.1D388 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaylor, Paul J | |
| 245 | 0 | 0 |
_aEffect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients. _h[electronic resource] |
| 260 |
_bThe Annals of pharmacotherapy _cFeb 2004 |
||
| 300 |
_a205-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacokinetics |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aHeptanoic Acids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHyperlipidemias _xdrug therapy |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostoperative Complications _xdrug therapy |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKubler, Paul A | |
| 700 | 1 | _aLynch, Stephen V | |
| 700 | 1 | _aAllen, Joan | |
| 700 | 1 | _aButler, Maree | |
| 700 | 1 | _aPillans, Peter I | |
| 773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 38 _gno. 2 _gp. 205-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1345/aph.1D388 _zAvailable from publisher's website |
| 999 |
_c14467611 _d14467611 |
||